Jennifer Dashnau

Jennifer Dashnau is Vice President of Analytical Development and Quality Control at Century Therapeutics. Prior to joining Century, she held various leadership roles at Merck in their Manufacturing and Supply Division, where she was responsible for process and assay development, technology transfer, process characterization and comparability, and validation for vaccine and monoclonal antibody products. While at Merck, she led CMC activities for six vaccine and two monoclonal antibody programs supporting late-stage development, licensure and commercial manufacturing. Jennifer began her career at Ortho-Clinical Diagnostics, a subsidiary of Johnson & Johnson, supporting quality control for in-vitro diagnostic products. She received her BS in Biotechnology and MBA in Technology Management and Quality & Applied Statistics from Rochester Institute of Technology and her PhD in Biochemistry and Molecular Biophysics from the University of Pennsylvania.